Pre-clinical Characterization of IBI343, a Site-Specifically Conjugated Anti-Claundin18.2 ADC, for Treating Solid Tumors
CANCER RESEARCH(2024)
AI Read Science
Must-Reading Tree
Example

Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined